DADC
AGN.PRA

D.A. Davidson & Co’s Allergan plc AGN.PRA Stock Holding History

D.A. Davidson & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,192
Closed -$699K – 1179
2017
Q4 		$699K Sell
1,192
-348
-23% -$225K 0.01% 556
2017
Q3 		$1.14M Buy
1,540
+52
+3% +$43.2K 0.02% 470
2017
Q2 		$1.29M Buy
1,488
+23
+2% +$19.3K 0.03% 403
2017
Q1 		$1.24M Buy
1,465
+14
+1% +$11.6K 0.03% 394
2016
Q4 		$1.1M Buy
1,451
+174
+14% +$131K 0.03% 445
2016
Q3 		$1.05M Buy
1,277
+168
+15% +$145K 0.03% 453
2016
Q2 		$924K Buy
1,109
+135
+14% +$113K 0.03% 414
2016
Q1 		$894K Sell
974
-38
-4% -$36.3K 0.03% 414
2015
Q4 		$1.04M Buy
1,012
+66
+7% +$66.3K 0.03% 389
2015
Q3 		$892K Buy
946
+211
+29% +$220K 0.03% 413
2015
Q2 		$768K Buy
+735
New +$769K 0.03% 458

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

D.A. Davidson & Co's AGN.PRA Position: Q1 2018 in Review

D.A. Davidson & Co sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,192 shares — an estimated $699K sold.

D.A. Davidson & Co first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $1.29M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • D.A. Davidson & Co reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,192 Allergan plc shares in Q1 2018, an estimated $699K.
  • D.A. Davidson & Co first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • D.A. Davidson & Co's Allergan plc position peaked at $1.29M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on D.A. Davidson & Co's 13F filing for Q1 2018, filed 4 May 2018.